News Poxel

Equities

POXEL

FR0012432516

Market Closed - Euronext Paris Other stock markets 11:37:30 2024-04-18 am EDT			5-day change	1st Jan Change
0.654 ^EUR	+6.34%		-0.76%	+18.69%

Apr. 11	Poxel: CDC falls below the 10% threshold	CF
Feb. 15	Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Poxel: CDC falls below the 10% threshold	Apr. 11	CF
Poxel to Report Its 2023 Annual Results by the End of April 2024	Mar. 28	BU
Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15	CI
Poxel Announces its Financial Calendar for 2024	Jan. 04	AQ
Poxel Provides Corporate Update	Dec. 22	AQ
Poxel: share price rises, boosted by savings plan	Dec. 22	CF
Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023	Nov. 09	AQ
Adrenoleukodystrophy Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	23-10-27	AQ
Poxel : Inside Information / Other news releases	23-10-12	PU
Poxel : Corporate Presentation	23-10-04	PU
Poxel Announces its Participation at Upcoming Scientific Conference	23-10-03	AQ
Global markets live: Coty, Sanofi, Ford, Spotify, Tesla...	23-09-26
Poxel Reports Financial Results for First Half 2023 and Provides a Corporate Update	23-09-26	AQ
Transcript : Poxel S.A., H1 2023 Earnings Call, Sep 26, 2023	23-09-26
Poxel S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-26	CI
Poxel : Inside Information / Other news releases	23-09-07	PU
Poxel : Corporate Presentation	23-09-05	PU
Poxel Announces Upcoming Participation at the H.C. Wainwright 2nd Annual Kidney Conference	23-07-19	AQ
Poxel : Corporate Presentation	23-07-18	PU
Poxel : Corporate Presentation	23-07-05	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer